Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Sector
Unknown
Region
US
AUM
42.28M
Fund Score
Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) Quotes, Forecast and News Summary
Roundhill GLP-1 & Weight Loss ETF (NASDAQ: OZEM) stock price, news, charts, stock research, profile.
| Open | $24.82 |
| High | $24.99 |
| 52 Wk High | $29.21 |
| AUM | 42.28M |
| Dividend | - |
| Ex-Div Date | - |
| Volume | 2.78K |
| Market Cap | - |
| Mgmt Fee | 0.59% |
| P/E Ratio | - |
| Prev. Close | $24.79 |
| Low | $24.82 |
| 52 Wk Low | $23.21 |
| Shares Out | - |
| Yield | - |
| Div. Freq | - |
| Avg. Volume Daily | 46.84K |
| Beta | 2.17 |
| Avg. Expense Ratio | 0.59% |
| P/B Ratio | - |
Recent News
FAQ
Q
How do I buy Roundhill GLP-1 & Weight Loss ETF (OZEM) stock?
A
You can purchase shares of Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) through any online brokerage.
Q
Who are Roundhill GLP-1 & Weight Loss ETF (OZEM) competitors?
A
There are no as such competitors for Roundhill GLP-1 & Weight Loss ETF.
Q
What is the forecast, or price target, for Roundhill GLP-1 & Weight Loss ETF (OZEM) stock?
A
There is no analysis for Roundhill GLP-1 & Weight Loss ETF to provide a consensus price target.
Q
What is the current price for Roundhill GLP-1 & Weight Loss ETF (OZEM)?
A
The stock price for Roundhill GLP-1 & Weight Loss ETF (NASDAQ: OZEM) is $24.99 last updated January 31, 2025 at 12:19 PM EST.
Q
Does Roundhill GLP-1 & Weight Loss ETF (OZEM) pay a dividend?
A
There are no upcoming dividends for Roundhill GLP-1 & Weight Loss ETF.
Q
When is Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) reporting earnings?
A
Roundhill GLP-1 & Weight Loss ETF does not have any upcoming earnings scheduled.
Q
Is Roundhill GLP-1 & Weight Loss ETF (OZEM) going to split?
A
There is no upcoming split for Roundhill GLP-1 & Weight Loss ETF.
| Open | $24.82 |
| High | $24.99 |
| 52 Wk High | $29.21 |
| AUM | 42.28M |
| Dividend | - |
| Ex-Div Date | - |
| Volume | 2.78K |
| Market Cap | - |
| Mgmt Fee | 0.59% |
| P/E Ratio | - |
| Prev. Close | $24.79 |
| Low | $24.82 |
| 52 Wk Low | $23.21 |
| Shares Out | - |
| Yield | - |
| Div. Freq | - |
| Avg. Volume Daily | 46.84K |
| Beta | 2.17 |
| Avg. Expense Ratio | 0.59% |
| P/B Ratio | - |
ETF Details
| Sector | Unknown |
| Category | - |
| Investment Style | Large Cap Blend |
| Fund Inception | May 21, 2024 |
| Managers | - |
| Definition | - |
Investment Policy
The Fund is an actively managed exchange-traded fund (ETF) that pursues its investment objective by seeking to provide exposure to companies involved in the development of pharmaceutical drugs and/or supplements that can be utilized to help individuals lose weight, maintain an ideal weight, and/or maintain body composition during weight loss (GLP-1 & Weight Loss Drugs).
Popular Channels
Tools & Features
Partners & Contributors
About Benzinga
© 2025 Benzinga | All Rights Reserved